New drugs for anemia of lower-risk MDS [MDS Patient & Family Report]

MDS Patient & Family Report
27/03/2024 27 min Temporada 3 Episodio 1
New drugs for anemia of lower-risk MDS [MDS Patient & Family Report]

Listen "New drugs for anemia of lower-risk MDS [MDS Patient & Family Report]"

Descargar episodio Ver en sitio original

Episode Synopsis

MDS experts Drs Nikolaos Papadantonakis of Emory, Atlanta, US, and Moshe Mittelman, Tel-Aviv, Israel, discuss new trials presented in the last meeting of the American Society of Hematology (ASH) 2023. They focus on luspatercept, imetelstat and roxodustat.  

More episodes of the podcast MDS Patient & Family Report

EHA 2025 updates [MDS Patient & Family Report] 26/09/2025
ASH 2024: MDS in Focus [MDS Patient & Family Report] 25/02/2025
MDS Highlights of the 2024 European Hematology Association Congress [MDS Patient & Family Report] 28/10/2024
Introduction to cytogenetics and mutational testing in MDS [MDS Patient & Family Report] 29/07/2024
Overview of MDS treatments [MDS Patient & Family Report] 30/04/2024
Commonly asked questions - Part II [MDS Patient & Family Report] 23/02/2024
Commonly asked questions - Part l [MDS Patient & Family Report] 26/01/2024
Clinical trials – What’s important to know? (Part II) [MDS Patient & Family Report] 25/12/2023
Clinical trials – What’s important to know? (Part I) [MDS Patient & Family Report] 19/11/2023
Blood transfusions and quality of life in MDS [MDS Patient & Family Report] 01/05/2023
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA